The 125I-antiTLR5 mAb could not target TLR5+ 4T1 tumor in group of pre-injecting unlabeled anti-TLR5 mAb, and tumors were not visualized by radiography, thus, confirming the specificity of 125I-antiTLR5 mAb imaging. Here, TLR5 is linked to neoplasm.